Dietary echium oil increases long-chain n-3 PUFAs, including docosapentaenoic acid, in blood fractions and alters biochemical markers for cardiovascular disease independently of age, sex, and metabolic syndrome

Journal of Nutrition

Volumn 144, Issue 4, 2014, Pages 447-460

  Kuhnt, Katrin ^a   Fuhrmann, Claudia ^a   Kö hler, Melanie ^a   Kiehntopf, Michael ^b   Jahreis, Gerhard ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ECHIUM OIL; FISH OIL; GAMMA GLUTAMYLTRANSFERASE; GAMMA LINOLENIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; INCROMEGA; LINOLENIC ACID; LONG CHAIN N 3 POLYUNSATURATED FATTY ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; STEARIDONIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DIET SUPPLEMENTATION; DISEASE MARKER; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ECHIUM; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; FISH OILS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; METABOLIC SYNDROME X; OVERWEIGHT; PHYTOTHERAPY; PLANT OILS; SEEDS; UP-REGULATION;

EID: 84896486218     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.113.180802     Document Type: Article

References (57)

1. Mozaffarian D, Wu JH. Omega-3 fatty acids and CVD: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58:2047-67.
2. Harris WS. The omega-3 index: from biomarker to risk marker to risk factor. Curr Atheroscler Rep. 2009;11:411-7.
3. Barceló-Coblijn G, Murphy EJ. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog Lipid Res. 2009;48:355-74.
4. American Heart Association. Fish 101 [updated 2013 Mar 20; cited 2013 Feb 26]. Available from: http://www.heart.org/HEARTORG/GettingHealthy/NutritionCenter/Fish-101_UCM_305986_Article.jsp.
5. Venegas-Calerón M, Sayanova O, Napier JA. An alternative to fish oils: metabolic engineering of oil-seed crops to produce omega-3 long chain polyunsaturated fatty acids. Prog Lipid Res. 2010;49:108-19.
6. Ruiz-López N, Sayanova O, Napier JA, Haslam RP. Metabolic engineering of the omega-3 long chain polyunsaturated fatty acids biosynthetic pathway into transgenic plants. J Exp Bot. 2012;63:2397-410.
7. Guil-Guerrero JL. Stearidonic acid (18:4n-3): metabolism, nutritional importance, medical uses and natural sources. Eur J Lipid Sci Technol. 2007;109:1226-36.
8. Hemaiswarya S, Raja R, Ravi Kumar R, Ganesan V, Anbazhagan C. Microalgae: a sustainable feed source for aquaculture. World J Microbiol Biotechnol. 2011;27:1737-46.
9. Kuhnt K, Degen C, Jaudszus A, Jahreis G. Searching for health beneficial n-3 and n-6 fatty acids in plant seeds. Eur J Lipid Sci Technol. 2012;114:153-60.
10. Diaz-Lopez M, Perez MJ, Acosta NG, Tocher DR, Jerez S, Lorenzo A, Rodriguez C. Effect of dietary substitution of fish oil by echium oil on growth, plasma parameters and body lipid composition in gilthead seabream (Sparus aurata L.). Aquacult Nutr. 2009;15:500-12.
11. James MJ, Ursin VM, Cleland LG. Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. Am J Clin Nutr. 2003;77:1140-5.
12. Ursin VM. Modification of plant lipids for human health: development of functional land-based omega-3 fatty acids. J Nutr. 2003;133:4271-4.
13. Ruiz-López N, Haslam RP, Venegas-Caleron M, Larson TR, Graham IA, Napier JA, Sayanova O. The synthesis and accumulation of stearidonic acid in transgenic plants: a novel source of ''heart-healthy'' omega-3 fatty acids. Plant Biotechnol J. 2009;7:704-16.
14. Harris WS. Stearidonic acid-enhanced soybean oil: a plant-based source of (n-3) fatty acids for foods. J Nutr. 2012;142:600S-4S
15. Banz WJ, Davis JE, Clough RW, Cheatwood JL. Stearidonic acid: is there a role in the prevention and management of type 2 diabetes mellitus?. J Nutr. 2012;142:635S-40S.
16. Kuhnt K, Kraft J, Moeckel P, Jahreis G. Trans-11-18:1 is effectively Delta9-desaturated compared with trans-12-18:1 in humans. Br J Nutr. 2006;95:752-61.
17. Kuhnt K, Kraft J, Vogelsang H, Eder K, Kratzsch J, Jahreis G. Dietary supplementation with trans11 and trans12 18:1 increases cis9,trans11 conjugatedlinoleic acid in human immune cells, but without effects on biomarkers of immune function and inflammation. Br J Nutr. 2007;97:1196-205.
18. Quinn FA, Armbruster DA. Abbott ARCHITECT family of analyzers. In: Wild D, editor. The immunoassay handbook. Theory and applications of ligand binding, ELISA and related techniques. 4th ed. Oxford (United Kingdom): Elsevier; 2013:561-6.
19. Tamimi W, Albanyan E, Altwaijri Y, Tamim H, Alhussein F. Age-and gender-specific reference intervals for fasting blood glucose and lipid levels in school children measured with Abbott Architect c8000 chemistry analyzer. Indian J Clin Biochem. 2012;27:141-6.
20. Thomas L. Labor und Diagnose. Indikation und Bewertung von Laborbefunden fü r die medizinische Diagnostik. 6th ed. Frankfurt/Main, Germany: TH-Books Verlagsgesellschaft; 2005.
21. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults-findings from the third national health and nutrition examination survey. JAMA. 2002;287:356-9.
22. Surette ME, Edens M, Chilton FH, Tramposch KM. Dietary echium oil increases plasma and neutrophil long-chain (n-3) fatty acids and lowers serum triacylglycerols in hypertriglyceridemic humans. J Nutr. 2004;134:1406-11.
23. Miles EA, Banerjee T, Calder PC. The influence of different combinations of gamma-linolenic, stearidonic and eicosapentaenoic acids on the fatty acids composition of blood lipids and mononuclear cells in human volunteers. Prostaglandins Leukot Essent Fatty Acids. 2004;70:529-38.
24. Harris WS, Lemke SL, Hansen SN, Goldstein DA, DiRienzo MA, Su H, Nemeth MA, Taylor ML, Ahmed G, George C. Stearidonic acid enriched soybean oil increased the omega-3 index, an emerging cardiovascular risk marker. Lipids. 2008;43:805-11.
25. Lemke SL, Vicini JL, Su H, Goldstein DA, Nemeth MA, Krul ES, Harris WS. Dietary intake of stearidonic acid-enriched soybean oil increases the omega-3 index: randomized, double-blind clinical study of efficacy and safety. Am J Clin Nutr. 2010;92:766-75.
26. Krul ES, Lemke SL, Mukherjea R, Taylor ML, Goldstein DA, Su H, Liu P, Lawless A, HarrisWS, Maki KC. Effects of duration of treatment and dosage of eicosapentaenoic acid and stearidonic acid on red blood cell eicosapentaenoic acid content. Prostaglandins Leukot Essent Fatty Acids. 2012;86:51-9.
27. Maki KC, Rains TM. Stearidonic acid raises red blood cell membrane eicosapentaenoic acid. J Nutr. 2012;142:626S-9S.
28. Kaur G, Cameron-Smith D, Garg M, Sinclair AJ. Docosapentaenoic acid (22:5n-3): a review of its biological effects. Prog Lipid Res. 2011;50:28-34.
29. Pawlosky RJ, Hibbeln JR, Novotny JA, Salem N. Physiological compartmental analysis of a-linolenic acid metabolism in adult humans. J Lipid Res. 2001;42:1257-65.
30. Goyens PL, Spilker M, Zock P, Katan M, Mensink R. Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. Am J Clin Nutr. 2006;84:44-53.
31. Sprecher H. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta. 2000;1486:219-31.
32. Vermunt SHF, Mensink RP, Simonis MMG, Hornstra G. Effects of dietary alpha-linolenic acid on the conversion and oxidation of C-13-alpha-linolenic acid. Lipids. 2000;35:137-42.
33. Cleland LG, Gibson RA, Pedler J, James MJ. Paradoxical effect of n-3 containing vegetable oils on long-chain n-3 fatty acids in rat heart. Lipids. 2005;40:995-8.
34. Emken EA, Adlof RO, Gulley RM. Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim Biophys Acta. 1994;1213:277-88.
35. Blasbalg TL, Hibbeln JR, Ramsden CE, Majchrzak SF, Rawlings RR. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr. 2011;93:950-62.
36. Liou YA, King DJ, Zibrik D, Innis SM. Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr. 2007;137:945-52.
37. Miles EA, Banerjee T, Dooper MM, M'Rabet L, Graus YM, Calder PC. The influence of different combinations of gamma-linolenic acid, stearidonic acid and EPA on immune function in healthy young male subjects. Br J Nutr. 2004;91:893-903.
38. Kew S, Mesa MD, Tricon S, Buckley R, Minihane AM, Yaqoob P. Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans. Am J Clin Nutr. 2004;79:674-81.
39. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y. Am J Clin Nutr. 2001;73:539-48.
40. Faber J, Berkhout M, Vos PV, Sijben JWC, Calder PC, Garssen J, van Helvoort A. Supplementation with a fish oil-enriched, high-protein medical food leads to rapid incorporation of EPA into white blood cells and modulates immune responses within one week in healthy men and women. J Nutr. 2011;141:964-70.
41. Sands SA, Reid KJ, Windsor SL, Harris WS. The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids. 2005;40:343-7.
42. Bolton-Smith C, Woodward M, Tavendale R. Evidence for age-related differences in the fatty acids composition of human adipose tissue, independent of diet. Eur J Clin Nutr. 1997;51:619-24.
43. Das UN. A defect in the activity of Delta6 and Delta5 desaturases may be a factor in the initiation and progression of atherosclerosis. Prostaglandins Leukot Essent Fatty Acids. 2007;76:251-68.
44. Childs CE, Romeu-Nadal M, Burdge GC, Calder PC. Gender differences in the n-3 fatty acid content of tissues. Proc Nutr Soc. 2008;67:19-27.
45. Jacobson TA. Role of n-3 fatty acids in the treatment of hypertriglyceridemia and CVD. Am J Clin Nutr. 2008;87:1981S-90S.
46. Calder PC. Mechanisms of action of (n-3) fatty acids. J Nutr. 2012;142:592S-9S.
47. Poudyal H, Panchal SK, Diwan V, Brown L. Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res. 2011;50:372-87.
48. Harris WS. n-3 Fatty acids and serum lipoproteins: Human studies. Am J Clin Nutr. 1997;65:1645S-54S.
49. Ebrahimi M, Ghayour-Mobarhan M, Rezaiean S, Hoseini M, Parizade SMR, Farhoudi F, Hosseininezhad SJ, Tavallaei S, Vejdani A, Azimi-Nezhad M, et al. Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity. Acta Cardiol. 2009;64:321-7.
50. Damsgaard CT, Frøkiaer H, Andersen AD, Lauritzen L. Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men. J Nutr. 2008;138:1061-6.
51. Finnegan YE, Minihane AM, Leigh-Firbank EC, Kew S, Meijer GW, Muggli R, Calder PC, Williams CM. Plant-and marine-derived n-3 polyunsaturated fatty acid have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am J Clin Nutr. 2003;77:783-95.
52. Zhang P, Boudyguina E, Wilson MD, Gebre AK, Parks JS. Echium oil reduces plasma lipids and hepatic lipogenic gene expression in apoB100-only LDL receptor knockout mice. J Nutr Biochem. 2008;19:655-63.
53. Botelho PB, Mariano Kda R, RogeroMM, de Castro IA. Effect of echium oil compared with marine oils on lipid profile and inhibition of hepatic steatosis in LDLr knockout mice. Lipids Health Dis. 2013;12:38.
54. Campioli E, Rustichelli C, Avallone R. n-3 Dietary supplementation and lipid metabolism: differences between vegetable-and fish-derived oils. J Funct Foods. 2012;4:207-12.
55. Suzuki T, Kohno H, Hasegawa A, Toshima S, Amaki T, KurabayashiM, Nagai R, Suzuki T, Amaki T, Nagai R, et al. Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease. Clin Biochem. 2002;35:347-53.
56. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447-55.
57. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369:1090-8.